Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Prevenir Retrasos y Trastornos del Lenguaje en Niños de Cuidadores con Trastornos por Uso de Sustancias Mediante Grupos Comunitarios y Servicios Individualizados

10 de noviembre de 2026 actualizado por: University of Oregon

Mejoras de Intervención Basadas en Evidencia para Reducir los Retrasos y Trastornos del Lenguaje en Niños de Padres con Trastornos por Consumo de Sustancias

The goal of this clinical trial is to test ways to improve early language development among young children of parents with substance use disorder (SUD). Children of parents with SUD are at increased risk for language delays, and early supports may help prevent long-term learning challenges. This study will examine whether adding additional supports to group-based parenting intervention improves child language outcomes compared to the group intervention alone.

Descripción general del estudio

Estado

Reclutamiento

Condiciones

Intervención / Tratamiento

Descripción detallada

The investigators will recruit and randomize a total of N=244 parent-child dyads to one of four treatment conditions using a 2x2 factorial design. Specifically, all participants will receive the group-based intervention from "Learn and Play Every Day" parent-implemented naturalistic communication intervention (PI-NCI) and will be randomized to receive the additional intervention modalities of (1) interaction review, (2) practical supports, (3) both, or (4) neither. The investigators will recruit participants from community agencies that provide support to adults with substance use disorders. Participants will be parents of a child between 18 and 42 months old and who have either a history of substance use disorder or active use within the last year (see Protection of Human Subjects for details). Interaction review and practical support intervention modalities will be conducted via telehealth. The investigators will randomize parents to intervention modality at the participant level through permuted blocks. The investigators will stratify randomization by the parent's primary language (English vs. Spanish) to ensure balance on this factor. Participant randomization will be masked to the interventionists delivering the group-based intervention. Interventionists delivering the interaction review and practical support modalities will not be aware of the presence or absence of the other intervention component. The investigators will collect information about parent responsivity and child language at baseline (T1, prior to receiving the intervention, immediately following the intervention (T2, 2 months), and at two follow-up assessments (T3, 4 months; T4, 6 months). Our primary analysis will compare pre-post gains in parent responsivity and child language comparisons between baseline and follow-up assessments. Parent-child interactions will be video recorded and then outcomes will be coded by trained staff, whereas child performance on the dynamic assessment task and parent performance on the functional cognitive-communication assessment will be scored in real-time by the data collector. Other self-reported measures such as demographics and substance use history will be collected through electronic survey software and stored on a secure server. The primary outcome of interest is parental responsivity, which is measured by the number of parental responses to intentional communicative acts from their child per minute. The secondary outcome of interest is child vocabulary (receptive and expressive). Additional outcomes include parenting knowledge and self-efficacy as well as secondary child outcomes such as rate of communication, sentence diversity, and language learning skill on the dynamic assessment task. Our primary interest (Aim 1a) is to compare the effectiveness of intervention modalities. The investigators will model changes in responsivity at two months post-baseline, as well as other outcomes, as a function of the intervention modalities and their interaction using generalized linear models adjusting for outcome values at baseline. Hypothesis tests will be conducted on the difference in outcome of each intervention modality from the mean of group means. Our overall judgment of the component will be primarily dependent on the component's effect on parental responsivity, but investigators will also take into account the effects on other parent and child outcomes. The investigators will conduct an intent-to-treat analysis, grouping participants by their treatment condition randomizations regardless of the fidelity of the intervention delivered. The effectiveness of an intervention can be undermined if it is difficult to administer or unacceptable to potential recipients. As a result, the investigators will collect feedback from parents, interventionists, and community partners through surveys and interviews. The questions posed will focus on evaluating the reach, acceptability, appropriateness, and fidelity of the intervention delivery (Aim 1b). The investigators will summarize and review the responses and use it to inform the interpretation of the results across Aim 1a and 1b. For example, if the interventions are found to be arduous to implement or unappealing to participants, this will be used to interpret the efficacy findings in context. In addition to assessing the efficacy and implementation of PI-NCI modalities, the investigators will assess differential treatment response and the mechanisms through which the intervention modalities function (Aim 2). The intervention modalities may not be equally effective across various psycho-social dimensions which may give opportunities for personalized treatment. Thus, investigators will assess the interactions (effect moderation) between the interventions and parental psychopathology, cognitive communicative impairment, social determinants of health on parental outcomes as well as prenatal exposure to substances on child outcomes. It is also important to understand how our interventions improve parental responsivity and other parent/child outcomes. Indeed, the investigators hypothesize that these interventions first improve parenting self-efficacy and knowledge, which in turn improves outcomes. Our analyses of mediators will use full information structural equation models to adjusted for baseline values and unbalanced covariates and the investigators will model moderators using similarly specified linear models. Our moderation analyses will assess the interaction terms between intervention components and our mediation analysis will examine the indirect effect of treatment modalities on outcomes through parenting efficacy and knowledge.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

244

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Stephanie De Anda, PhD, CCC-SLP
  • Número de teléfono: 541-346-8530
  • Correo electrónico: sdeanda@uoregon.edu

Copia de seguridad de contactos de estudio

  • Nombre: Maya Casper
  • Número de teléfono: 775-848-8727
  • Correo electrónico: mcasper@uoregon.edu

Ubicaciones de estudio

    • Oregon
      • Eugene, Oregon, Estados Unidos, 97403
        • Reclutamiento
        • Prevention Science Institute
        • Contacto:
        • Contacto:
          • Stephanie De Anda
          • Número de teléfono: 541-346-8530
          • Correo electrónico: sdeanda@uoregon.edu
        • Investigador principal:
          • Camille Cioffi

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  1. Have a:

    1. Self-reported lifetime history of substance use disorder treatment and/or
    2. active substance use in the past year
  2. Be providing care for/parenting a child at least 10% of the time who is:

    1. between the ages of 12-42 months
    2. English/Spanish bilingual or monolingual in English or Spanish
    3. exposed to a third language once a week or less
    4. not yet combining three or more words regularly
    5. has less than 150 words in their expressive vocabulary
  3. Be able to provide consent for their target child to participate, or have a legal guardian provide consent for the child to participate

  4. Be able to speak and understand English and/or Spanish

  5. Be willing to attend groups once a week for six weeks at a participating site/group time

  6. If assigned additional services, willing to attend virtual meetings

  7. Be 18 years of age or older

Exclusion Criteria:

-Only one caregiver per focal child can participate in the research study. Caregivers whose participating child already has another caregiver enrolled in the research study will not be eligible to participate.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Prevención
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación factorial
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Comparador activo: Interaction Review Enhancement & Practical Supports Enhancement

Participants receive the Comilia Group intervention plus the interaction review sessions and practical support sessions.

Parents participate in six weekly 90-minute in-person groups led by a trained facilitator and offered in English or Spanish. Groups use modeled caregiver-child interaction videos and guided discussion to teach evidence-based communication strategies.

Parents receive three one-hour telehealth coaching sessions with a licensed speech-language pathologist to review caregiver-child interactions, practice communication strategies, and receive individualized feedback.

Participants receive three one-hour telehealth sessions focused on identifying barriers to using the communication strategies introduced in the group sessions. Interventionists work with parents to develop structured supports (e.g., mindfulness tools, visual aids, tracking logs, timers) and set goals to address planning, attention, or memory challenges that may interfere with implementation.

Comparador activo: Comilia Group Only

Participants receive the Comilia Group intervention only.

Parents participate in six weekly 90-minute in-person groups led by a trained facilitator and offered in English or Spanish. Groups use modeled caregiver-child interaction videos and guided discussion to teach evidence-based communication strategies.

Comparador activo: Interaction Review Enhancement

Participants receive the Comilia Group intervention plus the Interaction Review Enhancement.

Parents participate in six weekly 90-minute in-person groups led by a trained facilitator and offered in English or Spanish. Groups use modeled caregiver-child interaction videos and guided discussion to teach evidence-based communication strategies.

Parents receive three one-hour telehealth coaching sessions with a licensed speech-language pathologist to review caregiver-child interactions, practice communication strategies, and receive individualized feedback.

Comparador activo: Practical Support Enhancement

Participants receive the Comilia Group intervention plus the Practical Support Enhancement.

Parents participate in six weekly 90-minute in-person groups led by a trained facilitator and offered in English or Spanish. Groups use modeled caregiver-child interaction videos and guided discussion to teach evidence-based communication strategies.

Participants receive three one-hour telehealth sessions focused on identifying barriers to using the communication strategies introduced in the group sessions. Interventionists work with parents to develop structured supports (e.g., mindfulness tools, visual aids, tracking logs, timers) and set goals to address planning, attention, or memory challenges that may interfere with implementation.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Parent responsivity
Periodo de tiempo: Baseline, 2 months, 4 months and 6 months

Rate-based measure that describes parent responses to child intentional communication acts.

Baseline, 2 months, 4 months and 6 months

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Receptive and expressive vocabulary
Periodo de tiempo: Baseline, 2 months, 4 months and 6 months

Will be assessed using the MacArthur Bates Communicative Development Inventory: specifically the Dual Language Learners English-Spanish Inventories.

Baseline, 2 months, 4 months and 6 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Colaboradores

Investigadores

  • Investigador principal: Camille Cioffi, Prevention Science Institute

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Enlaces Útiles

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

10 de marzo de 2026

Finalización primaria (Estimado)

30 de junio de 2029

Finalización del estudio (Estimado)

30 de noviembre de 2029

Fechas de registro del estudio

Enviado por primera vez

7 de abril de 2026

Primero enviado que cumplió con los criterios de control de calidad

7 de abril de 2026

Publicado por primera vez (Actual)

14 de abril de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

12 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

10 de noviembre de 2026

Última verificación

1 de octubre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • STUDY00002032
  • R01DC022028 (Subvención/contrato del NIH de EE. UU.)

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

All quantitative experimental data produced during the course of the project will be preserved and shared.

Marco de tiempo para compartir IPD

Shared data generated from this project will be made available as soon as possible, and no later than the time of publication or the end of the funding period, whichever comes first. The duration of preservation and sharing of the data will be a minimum of 10 years after the end of the funding period.

Criterios de acceso compartido de IPD

IPD will be stored in Databrary. Access to IPD is restricted to researchers who have been authorized by an institution, but broadly shared with all authorized researchers with password access. All shared materials are labeled with a sharing release level that reflects the permission granted by research participants or their parents or guardians.

Tipo de información de apoyo para compartir IPD

  • PROTOCOLO DE ESTUDIO
  • SAVIA
  • CIF

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .